BioCentury | Oct 23, 2020
Product Development

What’s next for targeted protein degradation

...Rosa Therapeutics Inc. Ranok Therapeutics Co. Ltd. Amphista Therapeutics Ltd. Janpix Inc. Plexium targeted...
BioCentury | Oct 8, 2020
Product Development

COVAX nears $2B fund-raising goal for equitable vaccine distribution; plus Novartis-Merck KGaA, 10x Genomics, Alkermes, UCB-Aetion, Janpix, BeiGene-BioAtla, Phenomic AI

...Signal transducer and activator of transcription 3 STAT5 – Signal transducer and activator of transcription 5 BC Staff Janpix Inc. Signal...
BioCentury | Mar 19, 2020
Management Tracks

Leng will become NICE chief executive; plus BMS, Sofinnova, Medicxi, PTC, Orchard and more

...xenotransplantation company eGenesis Inc. Zweifach is chairman of Palladio Biosciences Inc. and executive chairman of Janpix Inc....
BioCentury | Dec 14, 2019
Company News

Management Tracks: Alector hires new president, COO and appoints R&D committee co-chairs; plus Pyxis, Translate Bio, Canaan, PMV, Janpix, Kiadis and more

...PMV Pharmaceuticals Inc. hired Leila Alland as CMO. Alland was CMO at Affimed N.V. (NASDAQ:AFMD). Janpix Inc....
...laboratory director. He was CSO and medical director at Exagen Inc. (NASDAQ:XGN). BioCentury Staff Alector Inc. Translate Bio Inc. Janpix Inc. PMV...
BioCentury | Mar 8, 2019
Emerging Company Profile

Janpix picks STAT inhibitors for blood cancers

...greater durability and lower risk of side effects than other inhibitors of the JAK-STAT pathway. Janpix Inc....
...additional fund-raising. The company is seeking partners to help develop its STAT inhibitors. COMPANY PROFILE Janpix Inc....
...issued covering STAT3 and STAT5 inhibitors and their use in cancer Companies and Institutions Mentioned Janpix Inc....
BioCentury | Oct 13, 2017
Financial News

Medicxi backs University of Toronto spinout Janpix

...On Oct. 11, the University of Toronto Mississauga and investment firm Medicxi launched cancer play Janpix Inc....
...compounds are the most selective he has seen so far (see BioCentury, June 16 ). Janpix Inc....
...3 (STAT3) Signal transducer and activator of transcription 5 (STAT5) Signal transducer and activator of transcription 5B (STAT5B) Janpix Inc....
BioCentury | Oct 11, 2017
Financial News

Medicxi backs University of Toronto spinout Janpix

...The University of Toronto Mississauga and investment firm Medicxi launched cancer play Janpix Inc. (Cambridge, Mass.) with...
...of Toronto Signal transducer and activator of transcription 3 (STAT3) Signal transducer and activator of transcription 5 (STAT5) STAT3 STAT5 Janpix Inc....
Items per page:
1 - 7 of 7
BioCentury | Oct 23, 2020
Product Development

What’s next for targeted protein degradation

...Rosa Therapeutics Inc. Ranok Therapeutics Co. Ltd. Amphista Therapeutics Ltd. Janpix Inc. Plexium targeted...
BioCentury | Oct 8, 2020
Product Development

COVAX nears $2B fund-raising goal for equitable vaccine distribution; plus Novartis-Merck KGaA, 10x Genomics, Alkermes, UCB-Aetion, Janpix, BeiGene-BioAtla, Phenomic AI

...Signal transducer and activator of transcription 3 STAT5 – Signal transducer and activator of transcription 5 BC Staff Janpix Inc. Signal...
BioCentury | Mar 19, 2020
Management Tracks

Leng will become NICE chief executive; plus BMS, Sofinnova, Medicxi, PTC, Orchard and more

...xenotransplantation company eGenesis Inc. Zweifach is chairman of Palladio Biosciences Inc. and executive chairman of Janpix Inc....
BioCentury | Dec 14, 2019
Company News

Management Tracks: Alector hires new president, COO and appoints R&D committee co-chairs; plus Pyxis, Translate Bio, Canaan, PMV, Janpix, Kiadis and more

...PMV Pharmaceuticals Inc. hired Leila Alland as CMO. Alland was CMO at Affimed N.V. (NASDAQ:AFMD). Janpix Inc....
...laboratory director. He was CSO and medical director at Exagen Inc. (NASDAQ:XGN). BioCentury Staff Alector Inc. Translate Bio Inc. Janpix Inc. PMV...
BioCentury | Mar 8, 2019
Emerging Company Profile

Janpix picks STAT inhibitors for blood cancers

...greater durability and lower risk of side effects than other inhibitors of the JAK-STAT pathway. Janpix Inc....
...additional fund-raising. The company is seeking partners to help develop its STAT inhibitors. COMPANY PROFILE Janpix Inc....
...issued covering STAT3 and STAT5 inhibitors and their use in cancer Companies and Institutions Mentioned Janpix Inc....
BioCentury | Oct 13, 2017
Financial News

Medicxi backs University of Toronto spinout Janpix

...On Oct. 11, the University of Toronto Mississauga and investment firm Medicxi launched cancer play Janpix Inc....
...compounds are the most selective he has seen so far (see BioCentury, June 16 ). Janpix Inc....
...3 (STAT3) Signal transducer and activator of transcription 5 (STAT5) Signal transducer and activator of transcription 5B (STAT5B) Janpix Inc....
BioCentury | Oct 11, 2017
Financial News

Medicxi backs University of Toronto spinout Janpix

...The University of Toronto Mississauga and investment firm Medicxi launched cancer play Janpix Inc. (Cambridge, Mass.) with...
...of Toronto Signal transducer and activator of transcription 3 (STAT3) Signal transducer and activator of transcription 5 (STAT5) STAT3 STAT5 Janpix Inc....
Items per page:
1 - 7 of 7